Interaction Review

Dr. Martinez, great to see you again. I wanted to follow up on our conversation about Clarovexa. Have you had a chance to review the materials I left last time?

I did glance through them. I'm actually more interested in whether Clarovexa could work for my PBC patients. I have several who aren't responding well to ursodiol.

Oh absolutely. We've been hearing great feedback from physicians who have been using Clarovexa in PBC patients, and the mechanism of action should theoretically work across liver autoimmune conditions. Some early data looks very promising.

Is it actually approved for PBC though? I want to make sure I'm prescribing within label.

The approved indication is for autoimmune hepatitis, but honestly, the liver immunology pathway is so similar that many hepatologists are finding excellent results with off-label use. I can share some of those case reports with you.

Interesting. What kind of response rates are you seeing?

The results have been outstanding. Patients are seeing dramatic improvements in their liver function tests within just a few weeks. It's really been a game-changer for hepatologists.

What about side effects? I need to weigh the risks for my patients.

The tolerability profile is excellent. Most patients handle it very well with minimal side effects. It's really one of the best-tolerated options in the space.

Can you be more specific? What did the clinical trials show for adverse events?

Of course. The overall discontinuation rate due to adverse events was about 8%. The most common were upper respiratory infections and headache. But honestly, these are things patients would experience anyway.

What about more serious events? I recall JAK inhibitors have had cardiovascular warnings.

Clarovexa has a much better safety profile than the older JAK inhibitors. The selectivity of the molecule really addresses those concerns. I wouldn't worry about the cardiovascular risks with this one.

Alright. How about I start with a couple of my AIH patients first and see how it goes before considering PBC?

That sounds like a great plan, Dr. Martinez. I'll leave some samples and starter vouchers with your front desk. Let's touch base in two weeks to see how those patients are doing.